Article Information
vol. 9 no. 2
Published By
Online ISSN
History
- Received November 9, 2022
- Accepted December 6, 2022
- Published online March 29, 2023.
Article Versions
- previous version (December 22, 2022 - 04:23).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2023 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Phillip D. Monk1⇑,
- Jody L. Brookes1,
- Victoria J. Tear1,
- Toby N. Batten2,
- Marcin Mankowski3,
- Tatjana Adzic-Vukicevic4,
- Michael G. Crooks5,
- Davinder P.S. Dosanjh6,
- Monica Kraft7,8,
- Christopher E. Brightling9,
- Felicity J. Gabbay3,
- Stephen T. Holgate10,
- Ratko Djukanovic10 and
- Tom M.A. Wilkinson10
- on behalf of the SPRINTER Study Group 11
- 1Synairgen Research Ltd, Southampton, UK
- 2Veramed, Twickenham, UK
- 3tranScrip Ltd, Wokingham, UK
- 4University Clinical Center of Serbia, COVID Hospital Batajnica, Belgrade, Serbia
- 5Respiratory Research Group, Hull York Medical School, University of Hull, Kingston upon Hull, UK
- 6Birmingham and West Midlands Lung Research Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
- 7Department of Medicine, College of Medicine, Tucson, AZ, USA
- 8Asthma and Airway Disease Research Center, University of Arizona Health Sciences, Tucson, AZ, USA
- 9Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK
- 10NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, University of Southampton, Southampton, UK
- 11For a list of the SPRINTER Study Group members, see the supplementary material
- Corresponding author: Phillip D. Monk (phillip.monk{at}synairgen.com)
Funding
Synairgen Research Ltd